168 related articles for article (PubMed ID: 23546222)
1. Highlights of the 2012 Congress of the Society for Melanoma Research, 8-11 November 2012, Hollywood, CA.
Vultur A; Webster M; Villanueva J; Herlyn D
Melanoma Res; 2013 Jun; 23(3):237-40. PubMed ID: 23546222
[TBL] [Abstract][Full Text] [Related]
2. Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California.
Lo RS; Ribas A; Long GV; Ballotti R; Berger M; Willy H; Gibney GT; Bosenberg M; Bernstein E; Villanueva J; Smalley KS
Pigment Cell Melanoma Res; 2013 Jul; 26(4):E1-7. PubMed ID: 23551976
[No Abstract] [Full Text] [Related]
3. Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.
Coricovac D; Dehelean C; Moaca EA; Pinzaru I; Bratu T; Navolan D; Boruga O
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795011
[TBL] [Abstract][Full Text] [Related]
4. Emerging concepts and technologies in melanoma research.
Herlyn M
Melanoma Res; 2002 Feb; 12(1):3-8. PubMed ID: 11828252
[TBL] [Abstract][Full Text] [Related]
5. 5th Canadian Melanoma Conference: research frontiers.
van Kempen LC
Expert Rev Anticancer Ther; 2011 Jun; 11(6):845-8. PubMed ID: 21707280
[TBL] [Abstract][Full Text] [Related]
6. Frontline approach to metastatic BRAF-mutant melanoma diagnosis, molecular evaluation, and treatment choice.
Chapman PB; Hauschild A; Sondak VK
Am Soc Clin Oncol Educ Book; 2014; ():e412-21. PubMed ID: 24857132
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing to Guide Treatment of Advanced Melanoma.
Griewank KG; Schilling B
Am J Clin Dermatol; 2017 Jun; 18(3):303-310. PubMed ID: 28229402
[TBL] [Abstract][Full Text] [Related]
8. Melanoma genetics and the development of rational therapeutics.
Chudnovsky Y; Khavari PA; Adams AE
J Clin Invest; 2005 Apr; 115(4):813-24. PubMed ID: 15841168
[TBL] [Abstract][Full Text] [Related]
9. [What are expected improvements in the follow-up and treatment of stage I melanoma?].
Thomas L
Ann Dermatol Venereol; 1995; 122(5):378-88. PubMed ID: 8572482
[No Abstract] [Full Text] [Related]
10. Successes and limitations of targeted cancer therapy in melanoma.
Romano E; Michielin O
Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics of melanoma: implications for immune-based therapies.
Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M
Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.
Massi D; Mihic-Probst D; Schadendorf D; Dummer R; Mandalà M
Cancer Treat Rev; 2020 Aug; 88():102060. PubMed ID: 32619863
[TBL] [Abstract][Full Text] [Related]
13. Melanoma in 2011.
Wiseman MC
J Cutan Med Surg; 2011; 15 Suppl 1():S371-3. PubMed ID: 22469203
[No Abstract] [Full Text] [Related]
14. Epigenetic Regulation in Melanoma: Facts and Hopes.
Giunta EF; Arrichiello G; Curvietto M; Pappalardo A; Bosso D; Rosanova M; Diana A; Giordano P; Petrillo A; Federico P; Fabozzi T; Parola S; Riccio V; Mucci B; Vanella V; Festino L; Daniele B; Ascierto PA; Ottaviano M; On Behalf Of Scito Youth
Cells; 2021 Aug; 10(8):. PubMed ID: 34440824
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough therapies in melanoma.
Lianos GD; Mangano A; Rausei S; Roukos DH
Future Oncol; 2014 Apr; 10(5):781-4. PubMed ID: 24799059
[No Abstract] [Full Text] [Related]
16. Illuminating progression: tracking melanoma metastasis in a gene therapy setting.
Day CP; Merlino G
Pigment Cell Melanoma Res; 2011 Apr; 24(2):260-1. PubMed ID: 21226857
[No Abstract] [Full Text] [Related]
17. Melanoma and epigenetic treatment: past and future.
La Porta CA
Anticancer Agents Med Chem; 2012 Mar; 12(3):202-9. PubMed ID: 22044004
[TBL] [Abstract][Full Text] [Related]
18. Novel insights/translational implication from the emerging biology of melanoma.
Ribas A
Methods Mol Biol; 2014; 1102():3-9. PubMed ID: 24258970
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Rajkumar S; Watson IR
Br J Cancer; 2016 Jul; 115(2):145-55. PubMed ID: 27336610
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of melanoma.
Newton Bishop JA
Cancer Metastasis Rev; 1997 Jun; 16(1-2):141-54. PubMed ID: 9156284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
